Economic Atlas
Data may be delayed — last successful sync 2026-09-26 (18 days ago). Figures reflect the most recent completed ingest.
Companies/Profound Medical Corp.
Company profile

Profound Medical Corp.

NASDAQ: PROF · Healthcare · Medical - Devices
Canadian filerHQ Mississauga, ONCIK 0001628808Reports USD
#578 of 1,417 Healthcare companies by revenuetop-quartile growth
EA Score
44D
Revenue TTM
$18.7M
Rev growth YoY (TTM)
+33.8%
Net income (FY)
-$42.6M
Employees
162
as of 2026-09-14
Market cap
$213.3M
as of 2026-09-14

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$16.1M$16.1M2025
Net income-$42.6M-$42.6M2025
Operating income-$41.3M-$41.3M2025
Total assets$77.5M$77.5M2025
Liabilities$11.0M$11.0M2025
Equity$66.4M$66.4M2025

Revenue trend

FY2024 – FY2025 · USD
FY24
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Recurring - Non-Capital60%
Capital Equipment40%
By geography
UNITED STATES76%
CANADA19%
GERMANY5%
The read

What is Profound Medical Corp.’s revenue?

Profound Medical Corp. booked $16.1M in FY2025 revenue, growing 65% year over year — faster than most Healthcare companies we track, at a -264.4% net margin.

Peers · Healthcare
Seer, Inc.50DStem Holdings, Inc.——FOXO Technologies Inc.41DPatient Portal Technologies, Inc.——Green Growth Brands Inc.——Neuphoria Therapeutics Inc.44D
Key facts
CEOArun Swarup Menawat
SectorHealthcare
IndustryMedical - Devices
HeadquartersMississauga, ON
ExchangeNASDAQ: PROF
Employees162
IPO date2019-10-29
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.